Lam Research Corporation (NASDAQ:LRCX – Get Free Report) dropped 1.6% on Thursday . The stock traded as low as $229.64 and last traded at $231.29. Approximately 10,280,811 shares traded hands during mid-day trading, a decline of 24% from the average daily volume of 13,538,310 shares. The stock had previously closed at $235.12.
Analysts Set New Price Targets
Several equities analysts recently commented on LRCX shares. Citigroup boosted their price target on Lam Research from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Lam Research from $260.00 to $290.00 and gave the stock a “buy” rating in a research report on Thursday, January 29th. Wall Street Zen downgraded shares of Lam Research from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Summit Insights raised shares of Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. Finally, TD Cowen boosted their price objective on shares of Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $244.88.
Get Our Latest Analysis on Lam Research
Lam Research Stock Down 1.6%
Lam Research (NASDAQ:LRCX – Get Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same quarter in the previous year, the firm earned $0.91 EPS. The company’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.
Lam Research Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is currently 21.31%.
Insider Buying and Selling
In related news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director directly owned 253,705 shares of the company’s stock, valued at approximately $57,235,848. This represents a 12.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the transaction, the chief financial officer owned 987,237 shares in the company, valued at $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.31% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Lam Research
A number of institutional investors have recently modified their holdings of the business. PMV Capital Advisers LLC bought a new position in shares of Lam Research during the fourth quarter valued at approximately $25,000. IMG Wealth Management Inc. acquired a new position in Lam Research during the 2nd quarter valued at approximately $26,000. Stance Capital LLC bought a new position in Lam Research during the 3rd quarter worth $26,000. Howard Hughes Medical Institute acquired a new stake in Lam Research in the second quarter worth $27,000. Finally, Triumph Capital Management bought a new stake in Lam Research in the third quarter valued at $27,000. Institutional investors own 84.61% of the company’s stock.
Lam Research Company Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Featured Stories
- Five stocks we like better than Lam Research
- When to buy gold (mathematically)
- What a Former CIA Agent Knows About the Coming Collapse
- USAU: The U.S. Gold-Copper Story Investors Can’t Ignore.
- My Epstein Story
- Think You Missed Silver? You’re Wrong. Here’s Why.
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
